Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors
ConditionLymphoma
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorMassachusetts General Hospital
About this trial
The goal of this clinical trial is to learn if a mind body resilience group program can help increase lymphoma survivors' ability to cope with and manage the challenges that come with the transition into early post treatment survivorship.
Eligibility criteria
Qualifiers
English speaking adult (18 years or older at enrollment)
At least 6-months post-lymphoma diagnosis and within 2 years of completing active, curative treatment for lymphoma (includes surgery, chemotherapy/immunotherapy/radiation therapy, or other)
Disqualifiers
Active Psychiatric or cognitive comorbidity as determined by site PI or treating clinician
Unwilling or unable to participate using telehealth platform
Trial design
Treatments tested in this trial
- Enhanced Usual Care
- SMART3RP-Lymphoma
Treatment groups
254 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov